Shah Capital has ended its attempts to exert influence over vaccine developer Novavax, bringing more than years of activism ...

On paper, the programme was built. In practice, many never crossed the finish line. Demand was not the problem. In a June ...

The immunology alliance follows a collaboration between the UK Biobank and the University of Exeter, supported by the Novo ...

Pharmaceutical supply chains have more data at their fingertips than ever before. The challenge is turning that information into foresight. From temperature monitoring devices and connected containers ...

Swiss biotech Nouscom has closed a €120 million ($135 million) fourth-round financing for a vaccine to protect people with a ...